Evidence map›Paper›PMID 31546921›Full record

ReviewPharmaceutics2019

Injectable Hydrogels for Cancer Therapy over the Last Decade.

Giuseppe Cirillo, Umile Gianfranco Spizzirri, Manuela Curcio, Fiore Pasquale Nicoletta, Francesca Iemma

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. PLGA-based drug delivery systems in treating bone tumors.Frontiers in bioengineering and biotechnology · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. PCL-PEG copolymer based injectable thermosensitive hydrogels.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Review
  16. Review
  17. Review
  18. In Situ Hydrogels for Effective Treatment of Cancer: Strategies and Polymers Used.Recent advances in drug delivery and formulation · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giuseppe CirilloDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.ORCID 0000-0002-9592-1333
Umile Gianfranco SpizzirriDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy. g.spizzirri@unical.it.ORCID 0000-0002-5447-9497
Manuela CurcioDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy. manuela.curcio@unical.it.
Fiore Pasquale NicolettaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy. fiore.nicoletta@unical.it.ORCID 0000-0001-5961-1963
Francesca IemmaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy. francesca.iemma@unical.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interest in injectable hydrogels for cancer treatment has been significantly growing over the last decade, due to the availability of a wide range of starting polymer structures with tailored features and high chemical versatility. Many research groups are working on the development of highly engineered injectable delivery vehicle systems suitable for combined chemo-and radio-therapy, as well as thermal and photo-thermal ablation, with the aim of finding out effective solutions to overcome the current obstacles of conventional therapeutic protocols. Within this work, we have reviewed and discussed the most recent injectable hydrogel systems, focusing on the structure and properties of the starting polymers, which are mainly classified into natural or synthetic sources. Moreover, mapping the research landscape of the fabrication strategies, the main outcome of each system is discussed in light of possible clinical applications.

Indexed as

anticancer activitydrug deliveryinjectable hydrogelsnatural polymersstimuli-responsive materialssynthetic polymers

Identifiers

PMID31546921
PMCPMC6781516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.